MedPath

Ultrasound-Guided Erector Spinae Plane Block Versus Oblique Subcostal Transversus Abdominis Plane Block in Laparoscopic Cholecystectomy

Not Applicable
Completed
Conditions
Ultrasound
Erector Spinae Plane Block
Oblique Subcostal Transversus Abdominis Plane Block
Laparoscopic Cholecystectomy
Registration Number
NCT06640062
Lead Sponsor
Helwan University
Brief Summary

The aim of this work was to compare the effect of using oblique subcostal transversus abdominis plane (OSTAP) block and erector spinae plane (ESP) block as a part of multi-modal analgesia technique in patients undergoing laparoscopic cholecystectomy.

Detailed Description

Laparoscopic cholecystectomy is a commonly performed surgery and requires multi-modal analgesia for better control of pain. Untreated post-operative pain has many consequences, including patient dissatisfaction, transition into chronic pain, delayed discharge from the hospital, and increased healthcare costs.

Many inter-fascial plane blocks like oblique subcostal transversus abdominis plane (OSTAP) block and recently, erector spinae plane (ESP) block have been utilized as a part of multi modal analgesia technique in many abdominal surgeries.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Age from 20 to 60 years.
  • Both gender.
  • American Society of Anesthesiologists (ASA) grade I and II physical status.
  • Body mass index (BMI): ≥ 20 kg/m2 and ≤ 35 kg/m2.
  • Underwent laparoscopic cholecystectomy.
Exclusion Criteria
  • Patient refusal.
  • Known sensitivity or contraindication to drugs used in the study (local anesthetics, opioids).
  • History of psychological disorders and/or chronic pain syndrome.
  • Contraindication to regional anesthesia, e.g., local sepsis, pre-existing peripheral neuropathies, and coagulopathy.
  • Severe respiratory disorders such as (severe obstructive pulmonary disease, forced expiratory volume (FEV1), forced vital capacity (FVC) <50% or severe restrictive pulmonary disease, and adult respiratory distress syndrome).
  • Severe cardiac disorders such as (heart failure).
  • Advanced liver disease (elevated liver enzymes more than 3 folds of normal range).
  • Advanced kidney disease (Decreased creatinine clearance <40 ml/min).
  • Pregnancy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Degree of pain intensity24 hours postoperatively

The degree of pain intensity was assessed using the Visual Analogue Scale (VAS). Each patient was instructed about postoperative pain assessment with the VAS. VAS(0 represents "no pain" while 10 represents "the worst pain imaginable"). It was assessed at 30 minutes, 2, 4, 6, 8, 12, 16, 20, and 24 hours postoperatively.

Secondary Outcome Measures
NameTimeMethod
Total amount of morphine consumption24 hours postoperatively

When a patient complains of pain equivalent to the Visual Analogue Scale (VAS) ≥ 3, rescue analgesia is given in the form of morphine (0.05mg/kg) intravenous increments, as needed.

Incidence of adverse effects of the block technique24 hours postoperatively

Signs of adverse effects of the block techniques, such as local site infection, hematoma formation, bowel perforation, or pneumothorax, were recorded.

Time to first rescue analgesia24 hours postoperatively

Time to first rescue analgesia was assessed from the end of surgery to the first dose of morphine administrated

Morphine-related side effects24 hours postoperatively

Morphine-related side effects such as incidence of nausea and vomiting, respiratory depression (respiratory rate \< 8 breaths/min), bradycardia (heart rate decreases by \> 20% of basal reading), pruritus, and urine retention were recorded.

Local anesthetics-related side effects24 hours postoperatively

Local anesthetics-related side effects such as lightheadedness, circumoral numbness, tongue paresthesia, drowsiness, irritability, muscle twitches, convulsions, bradycardia, hypotension (mean arterial blood pressure decreases by \> 20% of basal reading), hypoventilation and cardiac arrest were recorded.

Trial Locations

Locations (1)

Helwan University

🇪🇬

Helwan, Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath